Novus Biologicals Announces New FUS Antibody made using SDIX Genomic Antibodies™

Novus Biologicals announced today a new FUS antibody (catalog number NBP1-50623) for neuroscience and cancer research. This FUS antibody was made using SDIX Genomic Antibody Technology™ (GAT™).

The RNA binding protein FUS is a component of nuclear riboprotein complexes and is thought to play a role in maintenance of genomic integrity. Novus’ new FUS antibody is useful for Western blot and immunofluorescent staining of human, mouse and bovine cells and tissues.

SDIX GAT uses sophisticated bioinformatics and immunization strategies to produce high-quality antibodies that specifically bind to targeted regions of the protein in its naturally folded form. The ability of an antibody to recognize a protein’s naturally folded state enables its utility in high-value applications like sandwich immunoassay, ChIP, and flow cytometry. Learn more about SDIX Genomic Antibodies™ by reading the SDIX Genomic Antibodies FAQ or by downloading the SDIX Genomic Antibodies White Paper.